Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This study is a post-marketing surveillance in Japan, and it is a local prospective, company
sponsored and observational study of patient who have been treated by Adalat CR for
hypertension with diabetes and/or chronic kidney disease. The objective of this study is to
assess safety and efficacy profile of using Adalat CR in real clinical practice. A total
2,000 patients will be recruited and be observed for 6 months. Then, patient of whom
microalbumin urea and serum creatinine are continuously monitored are additionally followed
for 6 months.